Two different IFN-gamma nonresponsive variants derived from the B-cell lymphoma 70Z/3

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• The kappa immunoglobulin (Igk) light chain locus is transcriptionally silent in mouse B-cell lymphoma 70Z/3 cells.
• Lipopolysaccharide (LPS) and interferon-gamma (IFN) induce significant Igk transcription in these cells.
• Understanding the signaling pathways involved in Igk gene activation is crucial for B-cell biology.

Purpose of the Study:

• To investigate the molecular mechanisms underlying LPS- and IFN-induced Igk gene transcription.
• To characterize B-cell lymphoma variants with differential responses to LPS and IFN.
• To elucidate the role of specific transcription factors and signaling pathways in Igk gene regulation.

Main Methods:

• Isolation of IFN-nonresponsive B-cell lymphoma variants (AT7.2 and AT3.3) via immunoselection.
• Analysis of Igk gene transcription, nuclear transcription factor binding (OTF-2, NF-kappa B, kBF-A), and enhancer region complex formation.
• Stable transfection experiments to assess gene rescue.

Main Results:

• The AT3.3 variant (IFN-LPS-) processes LPS and IFN signals into the nucleus but fails to activate Igk transcription.
• The AT7.2 variant (IFN-LPS+) shows defects in signal transduction in response to IFN, affecting enhancer binding complexes.
• Both variants possess intact Igk genes and normal IFN binding/uptake, indicating signaling pathway defects.

Conclusions:

• The AT3.3 variant provides a model for studying post-nuclear signaling events in Igk gene activation.
• The AT7.2 variant may harbor a defect in the IFN signal transduction pathway to the nucleus.
• These variants are valuable tools for dissecting the complex pathways regulating Igk transcription and IFN signaling in B cells.